Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
- Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.Active Not Recruiting
Sponsor: Imperial College London
Refractory Angina · Microvascular Angina · Microvascular Coronary Artery Disease · Coronary Disease
United Kingdom
- A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With AchondroplasiaEnrolling By Invitation
Sponsor: Ascendis Pharma Growth Disorders A/S
Achondroplasia
United States, Australia, Austria, Canada, Denmark +7 more
Sponsor: University of Leeds
Severe Asthma
United Kingdom
Sponsor: Vividion Therapeutics, Inc.
Advanced Solid Tumors · Colorectal Cancer
United States, Australia, Belgium, Canada, China +6 more
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNActive Not Recruiting
Sponsor: Medtronic Vascular
Hypertension · Vascular Diseases · Cardiovascular Diseases · Chronic Kidney Diseases
United States, Australia, Belgium, France, Germany +6 more
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: Generate Biomedicines
Severe Asthma
United States, Argentina, Australia, Belgium, France +6 more
Sponsor: Newcastle University
GNE Myopathy · Hereditary Inclusion Body Myopathy
United Kingdom
Sponsor: Azafaros B.V.
Niemann-Pick Type C Disease
United States, Argentina, Australia, Brazil, Canada +10 more
Sponsor: Queen's University, Belfast
PTSD - Post Traumatic Stress Disorder
United Kingdom
- Gyrate Atrophy Ocular and Systemic StudyActive Not Recruiting
Sponsor: Jaeb Center for Health Research
Gyrate Atrophy · Gyrata of Choroid and Retina; Atrophy · Ornithine-δ-aminotransferase · OAT
United States, Brazil, Canada, Finland, France +3 more
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: AstraZeneca
Gastroesophageal Adenocarcinoma
United States, Canada, China, Georgia, Italy +6 more
Sponsor: Tubulis GmbH
Ovarian Cancer · Non-small Cell Lung Cancer
United States, Belgium, Germany, Romania, Spain +2 more
Sponsor: Bristol-Myers Squibb
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
- Nailfold Capillaroscopy in PHRecruiting
Sponsor: University of Glasgow
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) · Pulmonary Hypertension (World Health Organization Group 3) · Chronic Thromboembolic Pulmonary Hypertension
United Kingdom
Sponsor: Pfizer
Non-muscle Invasive Bladder Cancer
United States, France, Israel, South Korea, Spain +1 more
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis
Australia, France, Germany, Hungary, Italy +6 more
Sponsor: Epitopea Ltd
Ovarian Cancer · HGSOC · HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
United Kingdom
Sponsor: Rezolute
Tumor Hyperinsulinism (Tumor HI)
United States, France, Netherlands, Switzerland, United Kingdom
- A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLCActive Not Recruiting
Sponsor: Amgen
Small Cell Lung Cancer (SCLC)
United States, Argentina, Australia, Belgium, Brazil +11 more
Sponsor: Stemline Therapeutics, Inc.
Breast Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Takeda
Ulcerative Colitis
United States, Australia, Belgium, Bulgaria, Canada +17 more
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Small-cell Lung Cancer
United States, Austria, Belgium, China, France +8 more
- A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.Active Not Recruiting
Sponsor: Vicore Pharma AB
Idiopathic Pulmonary Fibrosis (IPF)
United States, Argentina, Australia, Austria, Belgium +9 more